Cancer Registry Software Market by Type (Integrated and Standalone), by Database (Public and Commercial), by Delivery (Cloud and On-Premises), by Application (Cancer Reporting, Product Outcome Evaluation, Clinical Studies, Patient Care Management, and Medical Research), and by End-User (Hospitals, Healthcare Providers, Research Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Description

The report analyzes and forecasts the cancer registry software market on a global and regional level. The study offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The assessment of cancer registry software market dynamics gives a brief thought about the drivers and restraints of the cancer registry software market along with their impact on the demand over the years to come. Additionally, the report also includes the study of opportunities available in the cancer registry software market on a global level.

The report gives a transparent view of the cancer registry software market. We have included a detailed competitive scenario and portfolio of the leading vendors operating in the cancer registry software market. To understand the competitive landscape in the cancer registry software market, an analysis of Porter’s Five Forces model for the cancer registry software market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a crucial view of the cancer registry software market by segmenting it based on type, database, delivery, application, end-user, and region. All the market segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment comprises the current and forecast demand for the Middle East and Africa, North America, Asia Pacific, Latin America, and Europe.

Some noticeable players of the global cancer registry software market are McKesson Corporation, Elekta, C/NET Solutions, Electronic Registry Systems, Rocky Mountain Cancer Data Systems, and Onco.

This report segments the global cancer registry software market into:

Global Cancer Registry Software Market: By Type

• Integrated Software
• Standalone Software

Global Cancer Registry Software Market: By Database

• Public Database
• Commercial Database

Global Cancer Registry Software Market: By Application

• Cancer Reporting
• Product Outcome Evaluation
• Clinical Studies
• Patient Care Management
• Medical Research

Global Cancer Registry Software Market: By Delivery

• On-Premises
• Cloud

Global Cancer Registry Software Market: By End-User

• Hospitals
• Healthcare Providers
• Research Centers
• Others

Global Cancer Registry Software Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

Table Of Content

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Cancer Registry Software Market Revenue, 2016-2025 (USD Million)
  • 2.2. Global Cancer Registry Software Market: Snapshot
•  
• Chapter 3. Cancer Registry Software Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global Cancer Registry Software market drivers: Impact analysis
    • 3.2.2. Increasing incidence of cancer
    • 3.2.3. Improved healthcare
    • 3.2.4. Government initiatives
    • 3.2.5. Reduction of healthcare costs
    • 3.2.6. The rising importance of electronic health records
  • 3.3. Market Restraints
    • 3.3.1. Data security and privacy of data
  • 3.4. Opportunities
    • 3.4.1. Emerging Markets
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Type
    • 3.6.2. Market attractiveness analysis, by Database
    • 3.6.3. Market attractiveness analysis, by Application
    • 3.6.4. Market attractiveness analysis, by Delivery
    • 3.6.5. Market attractiveness analysis, by End-User
    • 3.6.6. Market attractiveness analysis, by Region
•  
• Chapter 4. Global Cancer Registry Software Market- Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Cancer Registry Software Market: Company Market Share, 2018
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Applications Launch
    • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
    • 4.2.4. Research and Development and Regional Expansion
•  
• Chapter 5. Global Cancer Registry Software Market - Type Analysis
  • 5.1. Global Cancer Registry Software Market: Type overview
    • 5.1.1. Global Cancer Registry Software Market Share, by Type, 2018 and 2025
  • 5.2. Integrated software
    • 5.2.1. Global Cancer Registry Software Market for Integrated Software, 2016-2025 (USD Million)
  • 5.3. Standalone software
    • 5.3.1. Global Cancer Registry Software Market for standalone software, 2016-2025 (USD Million)
•  
• Chapter 6. Global Cancer Registry Software Market - Application Analysis
  • 6.1. Global Cancer Registry Software Market: Application overview
    • 6.1.1. Global Cancer Registry Software Market Share, by Application, 2018 and 2025
  • 6.2. Cancer Reporting
    • 6.2.1. Global Cancer Registry Software Market for Cancer Reporting, 2016-2025 (USD Million)
  • 6.3. Product Outcome Evaluation
    • 6.3.1. Global Cancer Registry Software Market for product outcome evaluation, 2016-2025 (USD Million)
  • 6.4. Clinical Studies
    • 6.4.1. Global Cancer Registry Software Market for Clinical Studies, 2016-2025 (USD Million)
  • 6.5. Patient Care Management
    • 6.5.1. Global Cancer Registry Software Market for Patient Care Management, 2016-2025 (USD Million)
  • 6.6. Medical Research
    • 6.6.1. Global Cancer Registry Software Market for Medical Research, 2016-2025 (USD Million)
•  
• Chapter 7. Global Cancer Registry Software Market - Database Analysis
  • 7.1. Global Cancer Registry Software Market: Database overview
    • 7.1.1. Global Cancer Registry Software Market Share, by Database, 2018 and 2025
  • 7.2. Public Databases
    • 7.2.1. Global Cancer Registry Software Market for public databases, 2016-2025 (USD Million)
  • 7.3. Commercial Databases
    • 7.3.1. Global Cancer Registry Software Market for Commercial Databases, 2016-2025 (USD Million)
•  
• Chapter 8. Global Cancer Registry Software Market - Delivery Analysis
  • 8.1. Global Cancer Registry Software Market: Delivery overview
    • 8.1.1. Global Cancer Registry Software Market Share, by Delivery, 2018 and 2025
  • 8.2. Cloud
    • 8.2.1. Global Cancer Registry Software Market for Cloud, 2016-2025 (USD Million)
  • 8.3. On-premises
    • 8.3.1. Global Cancer Registry Software Market for On-premises, 2016-2025 (USD Million)
•  
• Chapter 9. Global Cancer Registry Software Market - End-User Analysis
  • 9.1. Global Cancer Registry Software Market: End-User overview
    • 9.1.1. Global Cancer Registry Software Market Share, by End-User, 2018 and 2025
  • 9.2. Hospitals
    • 9.2.1. Global Cancer Registry Software Market for Hospitals, 2016-2025 (USD Million)
  • 9.3. Research Centers
    • 9.3.1. Global Cancer Registry Software Market for Research Centers, 2016-2025 (USD Million)
  • 9.4. Healthcare Providers
    • 9.4.1. Global Cancer Registry Software Market for Healthcare Providers, 2016-2025 (USD Million)
  • 9.5. Others
    • 9.5.1. Global Cancer Registry Software Market for Others, 2016-2025 (USD Million)
•  
• Chapter 10. Global Cancer Registry Software Market - Regional Analysis
  • 10.1. Global Cancer Registry Software Market: Regional overview
    • 10.1.1. Global Cancer Registry Software Market Share, by region, 2018 and 2025
  • 10.2. North America
    • 10.2.1. North America Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
    • 10.2.2. North America Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
    • 10.2.3. North America Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
    • 10.2.4. North America Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
    • 10.2.5. North America Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.2.6. The U.S.
      • 10.2.6.1. The U.S. Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.2.6.2. The U.S. Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.2.6.3. The U.S. Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.2.6.4. The U.S. Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.2.6.5. The U.S. Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.2.7. Rest of North America
      • 10.2.7.1. Rest of North America Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.2.7.2. Rest of North America Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.2.7.3. Rest of North America Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.2.7.4. Rest of North America Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.2.7.5. Method of Administration, 2016-2025 (USD Million)
      • 10.2.7.6. Rest of North America Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
  • 10.3. Europe
    • 10.3.1. Europe Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
    • 10.3.2. Europe Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
    • 10.3.3. Europe Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
    • 10.3.4. Europe Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
    • 10.3.5. Europe Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.3.6. Germany
      • 10.3.6.1. Germany Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.3.6.2. Germany Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.3.6.3. Germany Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.3.6.4. Germany Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.3.6.5. Germany Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.3.7. U.K.
      • 10.3.7.1. U.K. Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.3.7.2. U.K. Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.3.7.3. U.K. Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.3.7.4. U.K. Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.3.7.5. U.K. Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.3.8. France
      • 10.3.8.1. France Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.3.8.2. France Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.3.8.3. France Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.3.8.4. France Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.3.8.5. France Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.3.9. Rest of Europe
      • 10.3.9.1. Rest of Europe Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.3.9.2. Rest of Europe Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.3.9.3. Rest of Europe Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.3.9.4. Rest of Europe Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.3.9.5. Rest of Europe Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
    • 10.4.2. Asia Pacific Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
    • 10.4.3. Asia Pacific Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
    • 10.4.4. Asia Pacific Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
    • 10.4.5. Asia Pacific Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.4.6. China
      • 10.4.6.1. China Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.4.6.2. China Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.4.6.3. China Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.4.6.4. China Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.4.6.5. China Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.4.7. Japan
      • 10.4.7.1. Japan Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.4.7.2. Japan Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.4.7.3. Japan Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.4.7.4. Japan Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.4.7.5. Japan Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.4.8. India
      • 10.4.8.1. India Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.4.8.2. India Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.4.8.3. India Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.4.8.4. India Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.4.8.5. India Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.4.9. Rest of Asia Pacific
      • 10.4.9.1. Rest of Asia Pacific Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.4.9.2. Rest of Asia Pacific Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.4.9.3. Rest of Asia Pacific Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.4.9.4. Rest of Asia Pacific Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.4.9.5. Rest of Asia Pacific Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
  • 10.5. Latin America
    • 10.5.1. Latin America Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
    • 10.5.2. Latin America Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
    • 10.5.3. Latin America Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
    • 10.5.4. Latin America Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
    • 10.5.5. Latin America Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.5.6. Brazil
      • 10.5.6.1. Brazil Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.5.6.2. Brazil Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.5.6.3. Brazil Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.5.6.4. Brazil Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.5.6.5. Brazil Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
    • 10.5.7. Rest of Latin America
      • 10.5.7.1. Rest of Latin America Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
      • 10.5.7.2. Rest of Latin America Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.5.7.3. Rest of Latin America Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
      • 10.5.7.4. Rest of Latin America Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
      • 10.5.7.5. Rest of Latin America Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
  • 10.6. The Middle East and Africa
    • 10.6.1. The Middle East and Africa Cancer Registry Software Market Revenue, by Type, 2016-2025 (USD Million)
    • 10.6.2. The Middle East and Africa Cancer Registry Software Market Revenue, by Database, 2016-2025 (USD Million)
    • 10.6.3. The Middle East and Africa Cancer Registry Software Market Revenue, by Application, 2016-2025 (USD Million)
    • 10.6.4. The Middle East and Africa Cancer Registry Software Market Revenue, by Delivery, 2016-2025 (USD Million)
    • 10.6.5. The Middle East and Africa Cancer Registry Software Market Revenue, by End-User, 2016-2025 (USD Million)
•  
• Chapter 11. Company Profile
  • 11.1. McKesson Corporation
    • 11.1.1. Overview
    • 11.1.2. Financials
    • 11.1.3. Therapy portfolio
    • 11.1.4. Business strategy
    • 11.1.5. Recent developments
  • 11.2. Elekta
    • 11.2.1. Overview
    • 11.2.2. Financials
    • 11.2.3. Therapy portfolio
    • 11.2.4. Business strategy
    • 11.2.5. Recent developments
  • 11.3. C/NET Solutions
    • 11.3.1. Overview
    • 11.3.2. Financials
    • 11.3.3. Therapy portfolio
    • 11.3.4. Business strategy
    • 11.3.5. Recent developments
  • 11.4. Electronic Registry Systems
    • 11.4.1. Overview
    • 11.4.2. Financials
    • 11.4.3. Therapy portfolio
    • 11.4.4. Business strategy
    • 11.4.5. Recent developments
  • 11.5. Rocky Mountain Cancer Data Systems
    • 11.5.1. Overview
    • 11.5.2. Financials
    • 11.5.3. Therapy portfolio
    • 11.5.4. Business strategy
    • 11.5.5. Recent developments
  • 11.6. Onco
    • 11.6.1. Overview
    • 11.6.2. Financials
    • 11.6.3. Therapy portfolio
    • 11.6.4. Business strategy
    • 11.6.5. Recent developments
    • 11.6.6. Therapy portfolio
    • 11.6.7. Business strategy
    • 11.6.8. Recent developments

Methodology

Free Analysis

Cancer registry software maintains records of cancer incidences, lists down the causes and current techniques of cancer healthcare that are being performed. It is a repository that contains information on cancer and its various implications. Cancer is one of the direst diseases and prevalent across various parts of the world. This, in turn, leads to the requirement to maintain a consistent data source to identify trends and consequently improve care and procedures for cancer patients. It is a computerized database that stores and organizes data via software solutions. The collected data is regarding special drugs, cancer outcomes, and biomedical devices along with providing access to such information for hospitals and other relevant users.

The cancer registry software market globally is growing due to the increasing cancer incidences, improved healthcare facilities, supportive government initiatives, reducing healthcare costs, rising importance of electronic healthcare records, and escalating requirement to use data related to cancer for surveillance. However, data security and issues related to the privacy of data may limit the cancer registry software market globally in the future. Conversely, there are varied software solutions available that can be used for special data collection. Many of these solutions are publicly available and are compliant with national standards.

The cancer registry software market is divided based on type, database, delivery, application, and end-user. Based on type, the market is divided into integrated and standalone software. By database, the market includes commercial and public databases. Based on delivery, the market is categorized into cloud and on-premises. The application segment comprises cancer reporting, product outcome evaluation, clinical studies, patient care management, and medical research. The end-user segment includes hospitals, healthcare providers, research centers, and others.

North America is most the significant contributor to the cancer registry software market share globally, mainly due to the increasing number of hospitals, rising cancer incidences, and growing government initiatives and investments in R&D and IT related to cancer. The European cancer registry software market holds a major share globally, due to the software’s ease of operability and efficient resource planning and rising government funding. This makes the software feasible for quick and easy implementation of business level software solutions in the healthcare market. Companies like Elekta provide highly precise treatments for cancer radiation and voxel-based tools. The Asia Pacific region will experience the highest CAGR in the cancer registry software market in the future, owing to the rapidly growing software demand in India and Singapore. There are various companies providing segment shape optimization, smart sequencing, and tools for data optimization while viewing research data on cancer. Due to enhancements in infrastructure, healthcare facilities, and hospitals, the Asia Pacific cancer registry software market is growing progressively.

Some noticeable players of the global cancer registry software market are McKesson Corporation, Elekta, C/NET Solutions, Electronic Registry Systems, Rocky Mountain Cancer Data Systems, and Onco.